Role of raloxifene in breast cancer prevention in postmenopausal women: Clinical evidence and potential mechanisms of action-Reference-Cited by-同舟云学术

Role of raloxifene in breast cancer prevention in postmenopausal women: Clinical evidence and potential mechanisms of action

Published:2004-06 Issue:6 Volume:26 Page:830-840
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Sporn Michael B.,Dowsett Sherie A.,Mershon John,Bryant Henry U.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference67 articles.

1. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial;Ettinger;JAMA,1999

2. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial;Ettinger;JAMA,1999

3. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation;Cauley;Breast Cancer Res Treat,2001

4. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-Year results from the MORE trial. Multiple outcomes of raloxifene evaluation;Cauley;Breast Cancer Res Treat,2001

5. Distinct effects of selective estrogen receptor modulators on estrogen dependent and estrogen independent human breast cancer cell proliferation;Short;J Bone Miner Res,1996

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oestrogen receptor positive breast cancer and its embedded mechanism: breast cancer resistance to conventional drugs and related therapies, a review;Open Biology;2024-06

2. Modulation of Estrogen Receptor Alpha (ERα) and Tumor Suppressor Gene BRCA1 in Breast Cancer Cells by Bazedoxifene Acetate (BZA);Cancers;2024-02-07

3. Raloxifene loaded d-α-tocopherol polyethylene glycol 1000 succinate stabilized poly (ε-caprolactone) nanoparticles augmented drug delivery and apoptosis in breast cancer cells;Journal of Drug Delivery Science and Technology;2024-02

4. Poly vinyl pyrrolidone (PVP) based inhaled delivery carriers for olaparib for non-small cell lung cancer (NSCLC) treatment;Journal of Drug Delivery Science and Technology;2023-09

5. Hyaluronated nanoparticles deliver raloxifene to CD44-expressed colon cancer cells and regulate lncRNAs/miRNAs epigenetic cascade;Cancer Nanotechnology;2023-04-07